IMPROVED IL-6 ANTIBODIES

IMPROVED IL-6 ANTIBODIES

Improved IL-6 antibodies are provided. Uses of the antibodies in the treatment of IL-6 related diseases, e.g., ocular diseases such as diabetic macular edema, are disclosed

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: SCHMIDT, MICHAEL MARCH, TISDALE, ALISON, FURFINE, ERIC STEVEN
Format: Patent
Sprache:eng
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator SCHMIDT, MICHAEL MARCH
TISDALE, ALISON
FURFINE, ERIC STEVEN
description Improved IL-6 antibodies are provided. Uses of the antibodies in the treatment of IL-6 related diseases, e.g., ocular diseases such as diabetic macular edema, are disclosed
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_MY185114A</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>MY185114A</sourcerecordid><originalsourceid>FETCH-epo_espacenet_MY185114A3</originalsourceid><addsrcrecordid>eNrjZJDw9A0I8g9zdVHw9NE1U3D0C_F08nfxdA3mYWBNS8wpTuWF0twMcm6uIc4euqkF-fGpxQWJyal5qSXxvpGGFqaGhiaOxgQVAAAymR5r</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>IMPROVED IL-6 ANTIBODIES</title><source>esp@cenet</source><creator>SCHMIDT, MICHAEL MARCH ; TISDALE, ALISON ; FURFINE, ERIC STEVEN</creator><creatorcontrib>SCHMIDT, MICHAEL MARCH ; TISDALE, ALISON ; FURFINE, ERIC STEVEN</creatorcontrib><description>Improved IL-6 antibodies are provided. Uses of the antibodies in the treatment of IL-6 related diseases, e.g., ocular diseases such as diabetic macular edema, are disclosed</description><language>eng</language><creationdate>2021</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20210430&amp;DB=EPODOC&amp;CC=MY&amp;NR=185114A$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,309,781,886,25566,76549</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20210430&amp;DB=EPODOC&amp;CC=MY&amp;NR=185114A$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>SCHMIDT, MICHAEL MARCH</creatorcontrib><creatorcontrib>TISDALE, ALISON</creatorcontrib><creatorcontrib>FURFINE, ERIC STEVEN</creatorcontrib><title>IMPROVED IL-6 ANTIBODIES</title><description>Improved IL-6 antibodies are provided. Uses of the antibodies in the treatment of IL-6 related diseases, e.g., ocular diseases such as diabetic macular edema, are disclosed</description><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2021</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZJDw9A0I8g9zdVHw9NE1U3D0C_F08nfxdA3mYWBNS8wpTuWF0twMcm6uIc4euqkF-fGpxQWJyal5qSXxvpGGFqaGhiaOxgQVAAAymR5r</recordid><startdate>20210430</startdate><enddate>20210430</enddate><creator>SCHMIDT, MICHAEL MARCH</creator><creator>TISDALE, ALISON</creator><creator>FURFINE, ERIC STEVEN</creator><scope>EVB</scope></search><sort><creationdate>20210430</creationdate><title>IMPROVED IL-6 ANTIBODIES</title><author>SCHMIDT, MICHAEL MARCH ; TISDALE, ALISON ; FURFINE, ERIC STEVEN</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_MY185114A3</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>2021</creationdate><toplevel>online_resources</toplevel><creatorcontrib>SCHMIDT, MICHAEL MARCH</creatorcontrib><creatorcontrib>TISDALE, ALISON</creatorcontrib><creatorcontrib>FURFINE, ERIC STEVEN</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>SCHMIDT, MICHAEL MARCH</au><au>TISDALE, ALISON</au><au>FURFINE, ERIC STEVEN</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>IMPROVED IL-6 ANTIBODIES</title><date>2021-04-30</date><risdate>2021</risdate><abstract>Improved IL-6 antibodies are provided. Uses of the antibodies in the treatment of IL-6 related diseases, e.g., ocular diseases such as diabetic macular edema, are disclosed</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language eng
recordid cdi_epo_espacenet_MY185114A
source esp@cenet
title IMPROVED IL-6 ANTIBODIES
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-18T10%3A41%3A30IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=SCHMIDT,%20MICHAEL%20MARCH&rft.date=2021-04-30&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EMY185114A%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true